Decision support analysis for risk identification and control of patients affected by COVID-19 based on Bayesian Networks.
Decision support analysis for risk identification and control of patients affected by COVID-19 based on Bayesian Networks.
复制标题
基于贝叶斯网络影响的患者的风险识别和控制患者的风险识别和控制的决策支持分析。
DOI:
10.1016/j.eswa.2022.116547
复制
发表时间:
2022-06-15
影响因子:
8.5
通讯作者:
Wu J
中科院分区:
文献类型:
--
作者:
Shen J;Liu F;Xu M;Fu L;Dong Z;Wu J
In the context of the outbreak of coronavirus disease (COVID-19), this paper proposes an innovative and systematic decision support model based on Bayesian networks (BNs) to identify and control the risk of COVID-19 patients spreading the virus, which requires the following three steps. First, by consulting the related literature and combining this with expert knowledge, we identify and classify the characteristics (risk factors) of COVID-19 and obtain a conceptual framework for COVID-19 Risk Assessment Bayesian Networks (CRABNs). Second, data on COVID-19 patients with expert scoring results on patient risk levels were collected from hospitals in Hubei Province of China and are used as the training set, and the structure and parameters of the CRABNs model are obtained through machine learning. Finally, we propose two indicators, namely, Model Bias and Model Accuracy, and use the remaining data to verify the feasibility and effectiveness of the CRABNs model to ensure that there are no significant differences between the predicted results of the model and the actual results provided by experts who have relevant experience in treating COVID-19. At the same time, we compared the CRABNs model with the support vector machine (SVM), random forest (RF), and k-nearest neighbour (KNN) models through four indicators: accuracy, sensitivity, specificity, and F-score. The results suggest the reliability of the model and show that it has promising application potential. The proposed model can be used globally by doctors in hospitals as a decision support tool to improve the accuracy of assessing the severity of COVID-19 symptoms in patients. Furthermore, with the further improvement of the model in the future, it can be used for risk assessments in the field of epidemics.
登录
查看更多内容
影响因子:
6.1
作者:
Fu, Lipeng;Wang, Xueqing;Li, Peixuan
通讯作者:
Li, Peixuan
DOI:
10.1016/s0888-613x(01)00039-1
发表时间:
2001-08-01
影响因子:
3.9
作者:
Onisko, A;Druzdzel, MJ;Wasyluk, H
通讯作者:
Wasyluk, H
影响因子:
8.7
作者:
Shaban WM;Rabie AH;Saleh AI;Abo-Elsoud MA
通讯作者:
Abo-Elsoud MA
影响因子:
8.4
作者:
De Nardo, Pasquale;Gentilotti, Elisa;Tacconelli, Evelina
通讯作者:
Tacconelli, Evelina
影响因子:
4.4
作者:
Caputo, Nicholas D.;Strayer, Reuben J.;Levitan, Richard
通讯作者:
Levitan, Richard